pharmacokinetic parameters

Related by string. Pharmacokinetic parameters * Pharmacokinetics . Pharmacokinetic . pharmacokinetics : pharmacokinetics PK . pharmacokinetic PK . safety tolerability pharmacokinetics . safety tolerability pharmacokinetic . favorable pharmacokinetic profile / Parameters . PARAMETERS : qualitative parameters . metabolic parameters . physiological parameters . lipid parameters * *

Related by context. Frequent words. (Click for all words.) 72 pharmacodynamic effects 69 safety tolerability pharmacokinetics 68 Pharmacokinetic 68 pharmacokinetic profiles 68 achieved statistical significance 67 pharmacodynamics 67 rHuPH# 67 pharmacodynamic 67 ascending doses 67 μg kg 66 serum concentrations 66 pharmacokinetic profile 66 pharmacokinetics 65 administered subcutaneously 65 pharmacokinetic studies 65 pharmacokinetic 64 mRNA expression 64 irbesartan 64 dose regimens 64 Secondary endpoints 64 #mg dose [001] 64 secondary efficacy endpoints 64 dosing regimens 64 active comparator 64 peripheral blood mononuclear 64 Cmax 63 biodistribution 63 CA4P 63 intravenously administered 63 mcg dose 63 efficacy 63 radiolabeled 62 tanespimycin 62 xenograft models 62 Secondary endpoints included 62 pharmacokinetic properties 62 PS# [001] 62 mg kg dose 62 glycemia 62 Phase 1b trial 62 6R BH4 62 haematological 62 safety tolerability 62 placebo controlled studies 62 plasma concentrations 62 subgroup analyzes 61 tolerated dose MTD 61 enfuvirtide 61 Imprime PGG 61 noninferiority 61 dose titration 61 tipranavir 61 T2DM 61 tolerability 61 Secondary endpoints include 61 biochemical markers 61 glargine 61 pertuzumab 61 dose cohorts 61 DAVANAT 61 intramuscularly 61 APOPTONE 61 Azedra 61 SCH # 61 nab paclitaxel 61 Phase 2a trial 61 placebo controlled clinical trials 61 limiting toxicity 61 Phase Ib clinical 61 serum phosphorus 61 Phase IIa trial 61 mycophenolate mofetil 61 C1 INH 61 serum calcium 61 immunohistochemical 60 Phase Ia 60 alkaline phosphatase 60 oral bioavailability 60 double blinded placebo 60 virologic 60 mcg kg 60 pg mL 60 montelukast 60 peginterferon alfa 2b 60 dose limiting toxicities 60 neoadjuvant 60 antihypertensive agents 60 PXD# 60 receptor antagonists 60 partial agonist 60 dose escalation trial 60 adecatumumab 60 Fludara 60 rNAPc2 60 ziprasidone 60 antiangiogenic 60 chlorambucil 60 nelfinavir 60 vitro studies 60 efficacy endpoints 59 Cloretazine R VNP#M

Back to home page